Literature DB >> 3112032

Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease.

M H Falk, H Tesch, H Stein, V Diehl, D B Jones, C Fonatsch, G W Bornkamm.   

Abstract

Three Hodgkin-derived cell lines (L428, L540, and CO) were studied for rearrangements and expression of immunoglobulin and T-cell receptor genes, and their genotype was compared to the phenotype. As far as the genotype is concerned, all 3 cell lines have characteristics of lymphoid cells; L428 of B, and L540 and CO of T-cell origin. L428 cells have one Ig heavy chain allele rearranged to C gamma and transcribed into RNA, while the second is deleted. Furthermore, L428 cells show an unusual immunoglobulin kappa light chain gene rearrangement involving deletion of the kappa constant gene in one allele, while the remaining kappa and lambda loci are in germline configuration. L540 and CO have, in contrast to L428 cells, the immunoglobulin genes in germline and T-cell receptor genes rearranged. The T-cell receptor beta and gamma genes are rearranged in both L540 and CO, whereas a rearrangement in the alpha locus was detected in L540 cells only. RNA of the size of functional beta chain transcripts was found in CO cells and of the size of functional alpha chain transcripts in L540 cells. All 3 cell lines are classified as immature lymphoid cells with respect to the limited expression of B- and T-cell antigens, respectively, and to the incomplete expression of their antigen receptor. The immaturity of lymphoid differentiation contrasts with the expression of activation antigens, i.e. Ki-1, Ki-24, HLA-DR, and IL-2 receptor. The immaturity of the cells excludes the possibility that the cells were activated along the physiological pathway, i.e. by interaction of the cell with antigen. The results obtained on the cell lines are in accordance with in vivo studies and suggest that Hodgkin and Sternberg-Reed cells are immature lymphoid cells which are activated by a still unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112032     DOI: 10.1002/ijc.2910400223

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Cytogenetics of malignant lymphomas.

Authors:  C Fonatsch
Journal:  Blut       Date:  1988-09

2.  L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

Authors:  S R Newcom; M E Kadin; A A Ansari; V Diehl
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease.

Authors:  M S Roth; B Schnitzer; E L Bingham; C E Harnden; D M Hyder; D Ginsburg
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

4.  Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).

Authors:  R Andreesen; W Brugger; G W Löhr; K J Bross
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.

Authors:  Roman Kurt Thomas; Anne Kallenborn; Claudia Wickenhauser; Joachim Ludwig Schultze; Andreas Draube; Martina Vockerodt; Daniel Re; Volker Diehl; Jürgen Wolf
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).

Authors:  G Gradl; H Tesch; G Schwieder; T Wagner; C Fonatsch
Journal:  Blut       Date:  1989-06

7.  Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues.

Authors:  J Irsch; S Nitsch; M L Hansmann; K Rajewsky; H Tesch; V Diehl; A Jox; R Küppers; A Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Chromosomal in situ hybridization of a Hodgkin's disease-derived cell line (L540) using DNA probes for TCRA, TCRB, MET, and rRNA.

Authors:  C Fonatsch; G Gradl; U Kolbus; H Rieder; H Tesch
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

9.  Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product.

Authors:  E Pócsik; R Mihalik; E Gyódi; M Réti; K Pálóczi; G G Petrányi; M Benczúr
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

10.  Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.

Authors:  H Tesch; A Günther; H Abts; M Jücker; S Klein; G R Krueger; V Diehl
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.